Skip to Content


Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


U.S. Nuclear Regulatory Commission.


Notice of meeting.


The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI). The agenda is under development, but will relate to issues arising from the revised 10 CFR part 35, Medical Use of Byproduct Material. To review agenda items as they become available, see​reading-rm/​doc-collections/​ acmui/schedules/2004/ or contact


ACMUI will hold a public meeting on March 1, 2004, from 8 a.m. to 5 p.m. On March 2, the ACMUI will convene at 8 a.m. for its public meeting, but will brief the Commission from 9:30 a.m.-12 p.m. At 1 p.m. on March 2, the ACMUI will recconvene, if necessary, to continue its public meeting until 5 p.m. The meeting and the Commission briefing will take place at the addresses provided below.


For Commission Briefing: U.S. Nuclear Regulatory Commission, One White Flint North Building, Commissioners' Conference Room 1G16, 11555 Rockville Pike, Rockville, MD, 20852-2738.

For Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Auditorium, 11545 Rockville Pike, Rockville, MD 20852-2738.

Start Further Info


Angela R. Williamson, telephone (301) 415-5030; e-mail of the Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001.

Conduct of the Meeting

Manuel D. Cerqueira, M.D., will chair the meeting. Dr. Cerqueira will conduct Start Printed Page 4186the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:

1. Persons who wish to provide a written statement should submit a reproducible copy to Angela R. Williamson, U.S. Nuclear Regulatory Commission, Two White Flint North, Mail Stop T8F5, 11545 Rockville Pike, Rockville, MD 20852-2738. Submittals must be postmarked by February 9, 2004, and must pertain to the topics on the agenda for the meeting.

2. Questions from members of the public will be permitted during the meeting, at the discretion of the Chairman.

3. The transcript and written comments will be available for inspection on NRC's Web site ( and at the NRC Public Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, telephone (800) 397-4209, on or about March 22, 2004. Minutes of the meeting will be available on or about May 3, 2004.

This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission's regulations in Title 10, U.S. Code of Federal Regulations, Part 7.

Start Signature

Dated: January 23, 2004.

Andrew L. Bates,

Advisory Committee Management Officer.

End Signature End Further Info End Preamble

[FR Doc. E4-131 Filed 1-27-04; 8:45 am]